Skip to main content
. Author manuscript; available in PMC: 2014 Aug 6.
Published in final edited form as: Lancet. 2010 Jun 30;376(9739):419–430. doi: 10.1016/S0140-6736(10)60576-4

Figure A10.

Figure A10

Kaplan-Meier curves for microvascular outcome Eye-4 (severe vision loss) by glycemia arm. Panel A: data until transition of intensive glycemia arm to standard therapy. Panel B: all data through end of study. Hazard ratios adjusted for baseline history of clinical cardiovascular disease and second trial treatment arm assignment.